On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Ariadne Diagnostics (United States)

InstitutionResearch output, impact & collaborations

Ariadne Diagnostics (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Ariadne Diagnostics (United States)?

ScholarIQrecord summary

Ariadne Diagnostics (United States) is a research organisation in Rockville, US. OpenAlex records 1,069 works and 192,636 citations for it. 196 researchers list it as their most recent affiliation.

How many works does Ariadne Diagnostics (United States) have?

ScholarIQindexed works

Ariadne Diagnostics (United States) has 1,069 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Ariadne Diagnostics (United States) →

How many citations does Ariadne Diagnostics (United States) have?

ScholarIQcitation count

Ariadne Diagnostics (United States) has 192,636 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Ariadne Diagnostics (United States) →

How many researchers are at Ariadne Diagnostics (United States)?

ScholarIQresearcher count

Ariadne Diagnostics (United States) has 196 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Ariadne Diagnostics (United States)?

ScholarIQavg h-index

Ariadne Diagnostics (United States) has an average h-index of 57.5 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Ariadne Diagnostics (United States)?

ScholarIQror

The ROR for Ariadne Diagnostics (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Ariadne Diagnostics (United States)?

ScholarIQopenalex

The OpenAlex for Ariadne Diagnostics (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Ariadne Diagnostics (United States)?

ScholarIQtop researchers by citations

Frank G. Haluska · Chronic Lymphocytic Leukemia Research

195 works28,213 citations

Tim Clackson · Chronic Myeloid Leukemia Treatments

210 works16,784 citations

What are the most-cited papers on Ariadne Diagnostics (United States)?

ScholarIQmost cited works

Analysis of human transcriptomes

Victor E. Velculescu, Stephen L Madden, Lin Zhang, Alex Lash, Jian Yu, Carlo Rago, Anita Lal, Clarence J. Wang, Gary A. Beaudry, Kristin M Ciriello, Brian P. Cook, Michael R. Dufault, Anne Ferguson, Yuhong Gao, Tong‐Chuan He, Heiko Hermeking, Siewleng K Hiraldo, Paul M. Hwang, Marissa A Lopez, Hilary F. Luderer, Brynna Mathews, Joseph M. Petroziello, Kornélia Polyák, Leigh Zawel, Wen Zhang, Xiaoming Zhang, Wei Zhou, Frank G. Haluska, Jin Jen, Saraswati Sukumar, Gregory M. Landes, Gregory J. Riggins, Bert Vogelstein, Kenneth W. Kinzler

Nature Genetics. 1999791 Citations

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial

Dong‐Wan Kim, Marcello Tiseo, Myung‐Ju Ahn, Karen L. Reckamp, Karin Holmskov Hansen, Sang‐We Kim, Rudolf M. Huber, Howard West, Harry J.M. Groen, Maximilian J. Hochmair, Natasha B. Leighl, Scott Gettinger, Corey J. Langer, Luis G. Paz-Ares Rodríguez, Egbert F. Smit, Edward S. Kim, William M. Reichmann, Frank G. Haluska, David Kerstein, D. Ross Camidge

Journal of Clinical Oncology. 2017585 CitationsOPEN ACCESS

Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial

Scott Gettinger, Lyudmila Bazhenova, Corey J. Langer, Ravi Salgia, Kathryn A. Gold, Rafael Rosell, Alice T. Shaw, Glen J. Weiss, Meera Tugnait, Narayana I. Narasimhan, David J. Dorer, David Kerstein, Victor M. Rivera, Timothy Piers Clackson, Frank G. Haluska, David Ross Camidge

The Lancet Oncology. 2016352 Citations

How much of the research on Ariadne Diagnostics (United States) is open access?

ScholarIQopen access share

33%OPEN ACCESS

Gold

Green

33%

Hybrid

Bronze

Closed

67%